Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor
- 22 August 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (19) , 5255-5258
- https://doi.org/10.1016/j.bmcl.2008.08.068
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 2007
- Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis CNew England Journal of Medicine, 2007
- Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonistBlood, 2007
- RomiplostimDrugs of the Future, 2007
- Single and Multiple Oral Doses of AKR-501 (YM477) Increase the Platelet Count in Healthy Volunteers.Blood, 2006
- EltrombopagDrugs of the Future, 2006
- Megakaryocyte biology and related disordersJournal of Clinical Investigation, 2005
- The molecular mechanisms that control thrombopoiesisJournal of Clinical Investigation, 2005
- Hydrazinonaphthalene and Azonaphthalene Thrombopoietin Mimics Are Nonpeptidyl Promoters of MegakaryocytopoiesisJournal of Medicinal Chemistry, 2001
- A non‐peptide compound which can mimic the effect of thrombopoietin via c‐MplFEBS Letters, 1998